Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 720 participants.

Also called NCT05732727

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 720 participants (planned count) (from the registry)
Sponsor
University Hospital, Tours (from the registry)
Registry
  • NCT NCT05732727
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05732727. Randomized; no masking; primary purpose treatment. Start 2023-03-28 (actual); primary completion 2029-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease
Acronym
THINK
Condition
Uncontrolled Hypertension
Intervention (Drug)
Antihypertensive algorithm
Intervention (Drug)
Standard of care
Lead sponsor
University Hospital, Tours (class: other)

Record details

Record id
cardio:ct-nct05732727
Content hash
a9ac3402192e3b48c21448db6c58cb6af9ae7bb29517866c8484e3b23a0ec187